| Tumor type | p | AUC of ROC | |
---|---|---|---|---|
Malignant (n = 17) | Benign (n = 13) | |||
Time intensity curve (TIC)* | ||||
Type 1 | 0 (0%) | 1 (7.7%) | 0.001 | Â |
Type 2 | 2 (11.8%) | 12 (92.3%) | 0.001 | Â |
Type 3 | 5 (29.4%) | 0 (0%) | 0.001 | Â |
Type 4 | 3 (17.6%) | 0 (0%) | 0.001 | Â |
Type 5 | 7 (41.2%) | 0 (0%) | 0.001 | Â |
Ktrans ** | ||||
Ktrans-1 (min−1) | 0.663 (0.350–4.634) | 0.117 (0.070–1.296) | 0.003 | 0.819 |
Ktrans-2 (min−1) | 0.486 (0.160–4.546) | 0.188 (0.780–1.338) | 0.001 | 0.846 |
Ktrans-3 (min−1) | 0.680 (0.215–3.470) | 0.156 (0.061–1.917) | 0.001 | 0.873 |
Kep** | ||||
Kep-1 (min−1) | 0.872 (0.227–5.032) | 0.270 (0.109–1.302) | 0.000 | 0.889 |
Kep-2 (min−1) | 0.583 (0.161–20.970) | 0.234 (0.106–1.340) | 0.003 | 0.824 |
Kep-3 (min−1) | 0.704 (0.212–4.903) | 0.239 (0.075–2.361) | 0.001 | 0.873 |
Ve** | ||||
Ve-1 | 0.972 (0.366–1.000) | 0.929 (0.252–1.000) | 0.340 |  |
Ve-2 | 0.991 (0.278–1.000) | 0.947 (0.390–1.000) | 0.506 |  |
Ve-3 | 0.996 (0.331–1.000) | 0.962 (0.328–1.000) | 0.550 |  |